Latest Regulatory Development News

Neuren Pharmaceuticals reports a 15% rise in 2025 royalties from its partner Acadia’s DAYBUE sales, with strong 2026 guidance signalling further growth. The launch of a new powder formulation and ongoing regulatory efforts in Europe and Japan add to the momentum.

Omni Bridgeway Limited reported a striking half-year performance with a 357% jump in net profit and a robust pipeline of legal finance investments. The company’s transformation into a capital-light fund manager is gaining momentum amid favourable regulatory shifts.

AI-Media Technologies has reported a robust first half of FY26, achieving an 80% increase in annual recurring revenue driven by its LEXI suite and unveiling a new Hardware as a Service model set to transform its business.

TPC Consolidated Limited reported a 4.1% revenue increase to $103.6 million and a 62% jump in underlying EBITDA for the half-year ended December 2025, while the proposed acquisition scheme faces regulatory hurdles.

Reef Casino Trust has reported a 4.8% increase in revenue and a 6.4% rise in net profit for 2025, supported by strong casino and hotel performance. Meanwhile, a takeover bid at $3.87 per unit is underway, backed by major unitholders and recommended by the board.

Aurizon Holdings reported a 9% rise in underlying EBITDA to $891 million for the half-year ending December 2025, driven by higher volumes and yields in coal and bulk segments. The company also raised its full-year dividend guidance and extended its share buy-back program.

Aussie Broadband has agreed to acquire AGL Telco’s telecommunications assets, adding 350,000 broadband and mobile connections and forming a long-term exclusive partnership with AGL. This deal positions Aussie Broadband as Australia’s third largest NBN provider.

Commonwealth Bank of Australia’s latest Basel III Pillar 3 disclosures reveal steady capital adequacy ratios and proactive adaptation to evolving regulatory standards as of December 2025.

Fortuna Metals has reported significant high-grade rutile mineralisation at its Mkanda project in Malawi, with assays from 96 drill holes revealing a mineralised footprint extending over 25km. The Malawi government has confirmed the company’s exemption from raw mineral export restrictions, supporting its in-country beneficiation plans.

News Corporation reported a 4% revenue increase to US$4.506 billion for the half-year ended December 2025, while net income declined 9% to US$305 million. The company declared an interim dividend and continued its stock repurchase program amid mixed segment performances and ongoing legal challenges.

Manuka Resources’ subsidiary Trans-Tasman Resources has received a draft decision proposing to decline consent for its Taranaki VTM iron sands project, challenging the company’s plans to develop a critical minerals supply in New Zealand.

The US Congress has reauthorized the Rare Pediatric Disease Priority Review Voucher program through September 2029, a move that could significantly benefit Neuren Pharmaceuticals as it advances its rare disease drug candidates.